Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Methyclothiazide measurement |
Component |
True |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methyclothiazide adverse reaction (disorder) |
Causative agent (attribute) |
True |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to methyclothiazide |
Causative agent (attribute) |
False |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely methyclothiazide 5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methyclothiazide 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing methyclothiazide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely deserpidine 250 microgram and methyclothiazide 5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely deserpidine 500 microgram and methyclothiazide 5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing deserpidine and methyclothiazide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing methyclothiazide and reserpine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to methyclothiazide |
Causative agent (attribute) |
True |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely methyclothiazide 5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely methyclothiazide 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methyclothiazide 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methyclothiazide 2.5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely deserpidine 250 microgram and methyclothiazide 5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely deserpidine 250 microgram and methyclothiazide 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet |
Has basis of strength substance (attribute) |
False |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely deserpidine 250 microgram and methyclothiazide 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely deserpidine 500 microgram and methyclothiazide 5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely deserpidine 500 microgram and methyclothiazide 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely deserpidine 500 microgram and methyclothiazide 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing deserpidine and methyclothiazide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely methyclothiazide 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methyclothiazide 2.5 mg oral tablet |
Has precise active ingredient |
True |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet |
Has precise active ingredient |
True |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely deserpidine 250 microgram and methyclothiazide 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing methyclothiazide and reserpine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing methyclothiazide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only deserpidine and methyclothiazide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Methyclothiazide and reserpine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only methyclothiazide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methyclothiazide and reserpine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only methyclothiazide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Deserpidine and methyclothiazide only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely deserpidine 250 microgram and methyclothiazide 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely deserpidine 500 microgram and methyclothiazide 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely deserpidine 500 microgram and methyclothiazide 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Methyclothiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |